Brief overview - PD, PK & ADME Flashcards
(11 cards)
1
Q
What is pharmacodynamics (2)
A
- Study of the effects of drugs and their mechanisms of actions
- What does the drug do to the body?
2
Q
What is pharmacokinetics (2)
A
- What the body does to the drug
- Absorption, Distribution, Metabolism, Excretion, (Toxicity) (ADME(T))
3
Q
What is the two-state model receptor theory (6)
A
- The receptor is shown in two confrontation states, Resting (R) and Activated (R*), which exist in equilibrium.
- No ligand = the equilibrium to left, more R.
- Agonists = affinity for R*, equilibrium to right.
- The greater the affinity for R* (activated), the greater the efficacy of the agonist
- Antagonist = higher affinity for R, equilibrium to the left.
- Neutral antagonist = equal affinity to R and R*, does affect, equilibrium, reduces by competition the binding of other ligands.
4
Q
Why are there spare receptors (4)
A
- Allow maximal response without total receptor occupancy
- Increasing the sensitivity of the system.
- bind (and internalise) extra ligands, preventing an exaggerated response if too much ligand is present.
- At half-maximal effect, ED50=KD. Sometimes, the full effect is see
5
Q
What are other mechanisms of antagonism (4)
A
- Chemical antagonism: Substances combine in solution
- Pharmacokinetic antagonism: ‘Antagonist’ reduces the concentration of the active drug at its site of action
- Block of receptor-effector linkage
- Physiological antagonism: opposing actions of two drugs cancel each other
6
Q
What is dimerisation/oligomerisation (3)
A
- Two or more receptors of the same receptor (homodimerisation)
or - Different receptors (heterodimerisation) functioning together as if they were a single receptor
- The pharmacology of dimer is distinct from that of each of the protomers.
7
Q
What are the mechanisms underlying desensitisation and tolerance (6)
A
- Change in receptors
- Translocation of receptors
- Exhaustion of mediators
- Increased metabolic degradation
- Physiological adaptation
- Active extrusion of drug from cells
8
Q
What is the paracellular route (2)
A
- Passive diffusion between cells; hydrophilic compounds e.g. Levothyroxine
- Experimental agents to modify pore diameter to absorption
9
Q
What is the transcellular route: passive diffusion (5)
A
- The most common mechanism for the oral route
- Compound moves from high to low concentration (Fick’s law)
- requires an appropriate balance of lipid & aqueous solubility
- Driven by the concentration gradient and lipid solubility
- (Most drugs have adequate aqueous solubility.)
10
Q
What are the 3 transporters and their locations (3)
A
- Large Neutral Amino Acid Transporter (LAT1) - Blood-Brain Barrier
- Organic Anion Transporter (OAT) - Brain; kidneys; placenta etc
- Organic Cation Transporter (OCT) - Liver; small intestine
11
Q
What are the locations and functions of P-gP (5)
A
- Intestine - Prevents chemical uptake into the system
- Liver - Excretion to bile / re-presents chemical to metabolising enzymes
- Kidney - Excretion into urine
- Brain - Prevents uptake into the brain
- Tumours- Prevents uptake of chemotherapeutic agents – drug-resistant tumours